Literature DB >> 8831680

Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action.

M R Sairam1, L G Jiang, T A Yarney, H Khan.   

Abstract

We have studied the functional properties of an alternately spliced form of sheep testicular FSH receptor cDNA that codes for a protein similar to a previously described active receptor but differs in the carboxy terminus in sequence and is also shorter by 25 residues. The receptor expressed in HEK 293 cells fails to activate adenylate cyclase. Cotransfection of stably expressing cells bearing FSH receptor that activates (Gs) adenylate cyclase with the altered receptor cDNA abrogates hormone response. In cells expressing this cDNA. FSH also inhibited cyclic AMP accumulation induced by non hormonal agents such as forskolin and cholera toxin which bypass the receptor. We propose that this altered receptor is a dominant negative receptor which may be coupled to G1 protein(s) or other inhibitory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831680     DOI: 10.1006/bbrc.1996.1419

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?

Authors:  Konstantinos Papadimitriou; Panteleimon Kountourakis; Anastasia E Kottorou; Anna G Antonacopoulou; Christian Rolfo; Marc Peeters; Haralabos P Kalofonos
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

2.  Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing.

Authors:  Richard M Thomas; Cheryl A Nechamen; Joseph E Mazurkiewicz; Marco Muda; Stephen Palmer; James A Dias
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

Review 3.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

4.  Dominant-negative mutations in the G-protein-coupled alpha-factor receptor map to the extracellular ends of the transmembrane segments.

Authors:  M Dosil; L Giot; C Davis; J B Konopka
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

5.  Extragonadal FSH receptor: is it real?

Authors:  T Rajendra Kumar
Journal:  Biol Reprod       Date:  2014-08-20       Impact factor: 4.285

6.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 7.  Current concepts of follicle-stimulating hormone receptor gene regulation.

Authors:  Jitu W George; Elizabeth A Dille; Leslie L Heckert
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

8.  Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH.

Authors:  Cengiz Karakaya; Ozlem Guzeloglu-Kayisli; Rebecca J Hobbs; Tsilya Gerasimova; Asli Uyar; Mehmet Erdem; Mesut Oktem; Ahmet Erdem; Seyhan Gumuslu; Deniz Ercan; Denny Sakkas; Pierre Comizzoli; Emre Seli; Maria D Lalioti
Journal:  Mol Hum Reprod       Date:  2014-03-25       Impact factor: 4.025

9.  Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys.

Authors:  Teresa Zariñán; Marco A Perez-Solís; Guadalupe Maya-Núñez; Patricia Casas-González; P Michael Conn; James A Dias; Alfredo Ulloa-Aguirre
Journal:  Mol Cell Endocrinol       Date:  2010-03-04       Impact factor: 4.102

10.  Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH.

Authors:  Tsilya Gerasimova; Maria N Thanasoula; Dimitrios Zattas; Emre Seli; Denny Sakkas; Maria D Lalioti
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.